Goldline Pharmaceutical SME IPO - Live Allotment Status

Alloted
Goldline Pharmaceutical SME

Goldline Pharmaceutical Limited, incorporated in 2021, is a pharmaceutical marketing company that operates under an asset-light business model. The company markets a wide range of pharmaceutical formulations under its proprietary brand 'Goldline', across five specialized divisions: Pharma (General), Cardinal (Specialty), Aayushman (Pediatric), InLife (Critical Care), and Wellness (Supportive Care). Instead of in-house manufacturing, Goldline partners with 15 third-party manufacturers and utilizes a network of 7 distributors to supply products to retailers and hospitals across Maharashtra, Tamil Nadu, Rajasthan, and other states.

Issue Price
43
Current GMP
15 (34.88%)
Est. Profit
45000
Est. Listing Price
58
Advertisement

IPO Details

Price Range
₹41.0 - ₹43.0
Issue Size
₹11.61 Cr
Lot Size
3000 shares
IPO Type
BSE SME
Open Date
12 May 2026
Close Date
14 May 2026
Allotment Date
15 May 2026
Listing Date
19 May 2026
Advertisement

How to Check Goldline Pharmaceutical SME IPO Allotment Status

Goldline Pharmaceutical SME IPO allotment status will be available on 15 May 2026. Here's how you can check:

Option 1: Via IPOwiz App

  1. Download the IPOwiz App from the Play Store.
  2. Add the PAN numbers you want to check in the PAN section.
  3. Go to the Allotted Section and select Goldline Pharmaceutical SME IPO.
  4. View the allotment status for the saved PAN numbers.

Option 2: Via Bigshare Services Website

  1. Visit the Bigshare Services Allotment Page.
  2. Select Goldline Pharmaceutical SME IPO from the drop-down menu.
  3. Enter your PAN number, application number, or demat account details.
  4. Click Search to view your allotment status.

Option 3: Via BSE Website

  1. Go to the BSE Website.
  2. Choose Goldline Pharmaceutical SME IPO from the list.
  3. Enter your PAN number, application number, or demat account details.
  4. Click Search to check your status.

Option 4: Via Demat Account

  1. Log in to your demat or trading account.
  2. Check if the allotted shares are credited. If yes, the shares will reflect in your account.

Option 5: Via Bank Account

  1. Log in to the bank account used for the IPO application.
  2. Check if the amount is debited. If debited, it means you've been allotted shares. If not, the amount will be refunded.

Join us on Telegram for instant IPO updates!

Join Now
Advertisement

Frequently Asked Questions

When will the Goldline Pharmaceutical SME IPO allotment be finalized?
Goldline Pharmaceutical SME IPO allotment will be finalized and available on 15 May 2026. You can check your allotment status after this date through various methods including the registrar's website, BSE, NSE, or your demat account.
How to check Goldline Pharmaceutical SME IPO allotment status?
You can check Goldline Pharmaceutical SME IPO allotment status through multiple methods: (1) IPOwiz App, (2) Bigshare Services website (https://ipo.bigshareonline.com/ipo_status.html), (3) BSE website using your application number or PAN, (4) NSE website, or (5) your demat/trading account. The easiest method is using your PAN number on the registrar's website.
What is the expected listing price of Goldline Pharmaceutical SME IPO?
Based on the current GMP of ₹15, the expected listing price for Goldline Pharmaceutical SME IPO is ₹58 (34.88% above the IPO price of ₹43). However, actual listing price may differ based on market conditions on the listing day.
When will shares be credited to demat accounts?
Shares will be credited to successful applicants' demat accounts by 16 May 2026, which is typically the next working day after the allotment date. Once credited, you can see the shares in your demat account and can sell them on the listing day.
When is Goldline Pharmaceutical SME IPO listing date?
The shares of Goldline Pharmaceutical SME IPO will list on BSE/NSE on 19 May 2026. Trading will begin on this date, and you can buy or sell the shares once the market opens.
Can I sell shares on listing day?
Yes, you can sell your allotted shares when trading begins on 19 May. Once the shares are credited to your demat account (by 16 May 2026), you can place a sell order on the listing day. Many investors choose to sell on listing day if the price is favorable.
What should I do if I'm not allotted shares?
If you're not allotted shares in Goldline Pharmaceutical SME IPO, the application money will be refunded to your bank account within a few days after the allotment date. The refund typically takes 2-3 working days. You don't need to take any action - the refund is processed automatically.
How is allotment done in IPO?
Allotment in IPO is done through a lottery system for oversubscribed categories. If the IPO is oversubscribed, shares are allocated randomly among applicants. For retail investors, if you applied for 1 lot and the IPO is oversubscribed, you may get partial allotment or no allotment. The allotment is finalized by 15 May 2026.
Can I check allotment status using PAN number?
Yes, you can check Goldline Pharmaceutical SME IPO allotment status using your PAN number on the Bigshare Services website (https://ipo.bigshareonline.com/ipo_status.html), BSE website, or NSE website. This is the easiest method as you don't need to remember your application number. Simply enter your PAN number and select the IPO.
Who should I contact for allotment queries?
For any queries regarding Goldline Pharmaceutical SME IPO allotment, you should contact the IPO registrar, Bigshare Services. You can visit their website at https://ipo.bigshareonline.com/ipo_status.html or contact them directly. The registrar handles all allotment-related processes and can help with status checks and refund queries.